白质高信号在CAD-RADS之外对疑似或已知冠心病患者主要不良心血管事件的增量预后价值
本研究纳入1085例同期行冠状动脉CT血管成像和脑MRI的疑似或已知冠心病患者,中位随访63.1个月,170例(15.7%)发生MACE。白质高信号(WMH)在调整临床变量或CAD-RADS后仍是MACE的独立危险因素,且加入WMH可显著提高C-statistic(训练集p=0.007、0.038,测试集p=0.002、0.004)。
要点
- WMH是疑似或已知CAD患者MACE的独立预后因素,独立于临床变量和CAD-RADS。
- 在临床模型或临床+CAD-RADS模型基础上加入WMH可显著提升对MACE的判别能力。
- 临床-CAD-RADS-WMH模型预测1、3、5年MACE的AUC在训练集为0.719、0.740、0.776,测试集为0.819、0.836、0.823。
核心结论
- WMH升高与疑似或已知CAD患者更高的MACE风险相关,且WMH在CAD-RADS之外对MACE具有增量预后价值。
研究设计与样本
- 采用时间依赖ROC曲线评估预测价值,C-statistic评估判别能力,中位随访63.1个月。
关键影像表现/征象
- 脑MRI显示白质高信号(WMH),其作为影像征象用于预测MACE,原文未描述具体信号特征或分级细节。
诊断标准与关键数值
- 训练集中临床-CAD-RADS-WMH模型预测1、3、5年MACE的AUC分别为0.719、0.740、0.776。
- 测试集中该模型预测1、3、5年MACE的AUC分别为0.819、0.836、0.823。
- 加入WMH至临床模型和临床+CAD-RADS模型均显著提高C-statistic(训练集p=0.007、p=0.038;测试集p=0.002、p=0.004)。
临床应用与阅片要点
- 在疑似或已知CAD患者行冠状动脉CTA时,可结合脑MRI评估WMH以辅助MACE风险分层。
- CAD-RADS报告之外,WMH可作为额外预后信息纳入影像综合评估。
局限性
- 单中心回顾性设计,可能存在选择偏倚。
- 原文未报告WMH的具体评估方法或分级标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to assess the additional prognostic value of white matter hyperintensity (WMH) beyond Coronary Artery Disease Reporting and Data System (CAD-RADS) for major adverse cardiovascular events (MACE) in patients with suspected or known coronary artery disease (CAD).
MATERIALS AND METHODS: This study included 1085 patients who underwent coronary computed tomography angiography and brain magnetic resonance imaging between November 2018 and December 2022. Time-dependent receiver operating characteristic curves were used to evaluate the predictive values, and the C-statistic was employed to determine their discriminatory power.
RESULTS: 170 (15.7%) patients experienced MACE during a median follow-up of 63.1 months. WMH remained a significant and independent risk factor for predicting MACE after adjustments with clinical variables alone or with CAD-RADS. In the training set, the clinical-CAD-RADS-WMH model showed area under the curves (AUCs) of 0.719, 0.740, and 0.776 for predicting MACE at 1, 3, and 5 years, respectively. The model showed a consistent performance trend with AUCs of 0.819, 0.836, and 0.823 in the test set over 1, 3, and 5 years, respectively. Both the addition of WMH to the clinical model and to the clinical plus CAD-RADS model significantly increased the C-statistic index (p = 0.007, p = 0.038 in the training set and p = 0.002, p = 0.004 in the test set). These trends continued to be present when WMH was analyzed as a continuous variable.
CONCLUSION: An elevated WMH was related to a higher risk of MACE in patients with suspected or established CAD. Moreover, WMH demonstrated additional prognostic value for MACE beyond CAD-RADS.
引用
- Huang Z, Cao B, Liu N, et al. Incremental Prognostic Value of White Matter Hyperintensity Beyond Coronary Artery Disease Reporting and Data System for Major Adverse Cardiovascular Events. Acad Radiol. 2026. PMID: 42919703. doi:10.1016/j.acra.2026.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。